Alan Young

635 total citations
21 papers, 502 citations indexed

About

Alan Young is a scholar working on Physiology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Alan Young has authored 21 papers receiving a total of 502 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Physiology, 11 papers in Pulmonary and Respiratory Medicine and 7 papers in Molecular Biology. Recurrent topics in Alan Young's work include Asthma and respiratory diseases (11 papers), Receptor Mechanisms and Signaling (6 papers) and Pharmacological Effects and Assays (6 papers). Alan Young is often cited by papers focused on Asthma and respiratory diseases (11 papers), Receptor Mechanisms and Signaling (6 papers) and Pharmacological Effects and Assays (6 papers). Alan Young collaborates with scholars based in United Kingdom, Singapore and Sweden. Alan Young's co-authors include Teresa D. Tetley, Peter Goldstraw, Andrew J. Thorley, Paul A. Ford, Mark A. Giembycz, Eric Lim, Iain G. Dougall, Roger V. Bonnert, Garry Pairaudeau and A. M. Davis and has published in prestigious journals such as The Journal of Immunology, PLoS ONE and The FASEB Journal.

In The Last Decade

Alan Young

19 papers receiving 490 citations

Peers

Alan Young
Jeffrey Drajesk United States
Lorelie Villarete United States
J G Hastewell United Kingdom
S. C. Flores United States
Donna L. Perry United States
Alan Young
Citations per year, relative to Alan Young Alan Young (= 1×) peers Kielan Darcy McAlinden

Countries citing papers authored by Alan Young

Since Specialization
Citations

This map shows the geographic impact of Alan Young's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alan Young with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alan Young more than expected).

Fields of papers citing papers by Alan Young

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alan Young. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alan Young. The network helps show where Alan Young may publish in the future.

Co-authorship network of co-authors of Alan Young

This figure shows the co-authorship network connecting the top 25 collaborators of Alan Young. A scholar is included among the top collaborators of Alan Young based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alan Young. Alan Young is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
3.
Nath, Puneeta, et al.. (2015). The effects of clinically relevant reference agents in a mouse model of severe asthma. OA1776–OA1776. 1 indexed citations
4.
Nath, Puneeta, et al.. (2014). Characterisation of a steroid-insensitive severe asthma model. European Respiratory Journal. 44(Suppl 58). P1781–P1781. 1 indexed citations
5.
Stocks, Michael J., Lilian Alcaraz, Andrew Bailey, et al.. (2014). Discovery of AZD3199, An Inhaled Ultralong Acting β2 Receptor Agonist with Rapid Onset of Action. ACS Medicinal Chemistry Letters. 5(4). 416–421. 16 indexed citations
6.
Pontén, Ingrid, P. Jane Mutch, David Nicholls, et al.. (2013). Micronucleus induction in the bone marrow of rats by pharmacological mechanisms. II: long-acting beta-2 agonism. Mutagenesis. 28(2). 233–239. 2 indexed citations
7.
Russell, Vincent, et al.. (2013). Steroid-insensitive tobacco smoke-induced lung inflammation models in the mouse. Journal of Inflammation. 10(Suppl 1). P31–P31. 1 indexed citations
8.
Nicholls, D.J., Shawn Jordan, Elaine Cadogan, et al.. (2012). Characteristics of AZD9708, a novel, selective β2-adrenoceptor agonist with rapid onset and long duration of action. Pulmonary Pharmacology & Therapeutics. 25(4). 293–302. 3 indexed citations
9.
Alcaraz, Lilian, Andrew Bailey, Elaine Cadogan, et al.. (2011). From libraries to candidate: The discovery of new ultra long-acting dibasic β2-adrenoceptor agonists. Bioorganic & Medicinal Chemistry Letters. 22(1). 689–695. 12 indexed citations
10.
Thorley, Andrew J., et al.. (2011). Innate Immune Responses to Bacterial Ligands in the Peripheral Human Lung – Role of Alveolar Epithelial TLR Expression and Signalling. PLoS ONE. 6(7). e21827–e21827. 75 indexed citations
11.
Connolly, Stephen, Lilian Alcaraz, Andrew Bailey, et al.. (2011). Design-driven LO: The discovery of new ultra long acting dibasic β2-adrenoceptor agonists. Bioorganic & Medicinal Chemistry Letters. 21(15). 4612–4616. 13 indexed citations
12.
Young, Alan, David Nicholls, Stephen Connolly, et al.. (2011). The In Vivo Profile Of AZD3199: A Novel, Fast Acting B2-Agonist With A Long Duration Of Action. A1586–A1586. 4 indexed citations
13.
Young, Alan, David Nicholls, Stephen Connolly, et al.. (2011). AZD3199: A Potent And Selective Beta2-Adrenergic Receptor Agonist With Rapid Onset Of Action. A1585–A1585. 1 indexed citations
14.
Thorley, Andrew J., Paul A. Ford, Mark A. Giembycz, et al.. (2007). Differential Regulation of Cytokine Release and Leukocyte Migration by Lipopolysaccharide-Stimulated Primary Human Lung Alveolar Type II Epithelial Cells and Macrophages. The Journal of Immunology. 178(1). 463–473. 179 indexed citations
15.
Thorley, Andrew J., Peter Goldstraw, Alan Young, & Teresa D. Tetley. (2004). Primary Human Alveolar Type II Epithelial Cell CCL20 (Macrophage Inflammatory Protein-3α)–Induced Dendritic Cell Migration. American Journal of Respiratory Cell and Molecular Biology. 32(4). 262–267. 73 indexed citations
16.
17.
Dougall, Iain G., et al.. (2003). Dual dopamine D2 receptor and beta2-adrenoceptor agonists for the treatment of chronic obstructive pulmonary disease: the pre-clinical rationale.. PubMed. 97 Suppl A. S3–7. 11 indexed citations
18.
Austin, Rupert P., Patrick Barton, Roger V. Bonnert, et al.. (2003). QSAR and the Rational Design of Long-Acting Dual D2-Receptor/β2-Adrenoceptor Agonists. Journal of Medicinal Chemistry. 46(15). 3210–3220. 51 indexed citations
19.
Young, Alan, et al.. (2000). Duration of Action of Inhaled vs. Intravenous β2-Adrenoceptor Agonists in an Anaesthetized Guinea-pig Model. Pulmonary Pharmacology & Therapeutics. 13(6). 287–292. 9 indexed citations
20.
Bonnert, Roger V., Roger C. Brown, David A. Chapman, et al.. (1998). Dual D2-Receptor and β2-Adrenoceptor Agonists for the Treatment of Airway Diseases. 1. Discovery and Biological Evaluation of Some 7-(2-Aminoethyl)- 4-hydroxybenzothiazol-2(3H)-one Analogues. Journal of Medicinal Chemistry. 41(25). 4915–4917. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026